1Haffner SM, Lehto S, Ronnemaa T, et al, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with an without prior myocardial infarction, N Engl J Med 1998;339:229-234.
2Executive summary of the third report of the National Cholesterol Eduction Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment PanelⅢ),JAMA 2001;285:2486-2497.
3Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. Arch Intern Med 2011 ; 161 : 1717-1723.
4De Vriese AS, Verbeuren TJ, Van de Voorde J, et al, Endothelial dysfunction in diabetes. Br J Pharmacol 2000 ; 130 : 963-974.
5Schmidet AM, Stern D. Atherosclerosis and diabetes Curr theroscler Rep 2000 ;2: 320- 436.
6Dichd W, Nillson, Goncalves 1, et al, Very lowdensity ipoprotein activates nuclear factor- kappaB in endothelial cels.Circ res 1999;84:1085- 1094.
7Uemura S, Matsushita h, Li W, et al. Diabetes mellitus enhances vascular matrix metalloprotelnase activity, Circ Res2001;88: 1291- 1298.
8Suzuki LA, Poot M, Gerrity RG, Bornfeldt KE. Diabetes acelerates smooth muscle accumulation in lesions of atherosclerosis. Diabetes 2002 ; 50:951 - 860.
9Vinik AI, Erbas T, Park TS, et al. Platelet dysfunction in type 2 diabetes. Diabetes Care 2001 ;24:1476- 1485.
10Gowri MS, Van der Westhuyzen DR, Bridges SR, Anderson JW. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may bd due to the abnormal composition of HDL. Arterioscler Thromb Vasc Biol 1999 ; 19 : 226- 2233.
5Scontt M,David J,Carol M,et al.Enhanced experssion of intracellular adhension molecule-1 and P-aslectin in the diabetic human retina and choroid [J].Am J Pathol,1995,14(7):642-653.
